Process View
The chemical reactions and pathways involving glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars. Formerly known as mucopolysaccharides, they include hyaluronic acid and chondroitin, which provide lubrication in joints and form part of the matrix of cartilage. The three-dimensional structure of these molecules enables them to trap water, which forms a gel and gives glycosaminoglycans their elastic properties.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "glycosaminoglycan metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.923 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.777 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.761 | Human | |
| TEK | TEK tyrosine kinase, endothelial | 0.634 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.579 | Human | |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.575 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.542 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.479 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.396 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.365 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.263 | ||
| HIP1 | huntingtin interacting protein 1 | 0.223 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.215 | Human | |
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.179 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.162 | Human | |
| NUMB | numb homolog (Drosophila) | 0.127 | ||
| FGA | fibrinogen alpha chain | 0.123 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.106 | ||
| NRP1 | neuropilin 1 | 0.095 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.085 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.081 | ||
| ENG | endoglin | 0.073 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.066 | ||
| THBS1 | thrombospondin 1 | 0.065 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.061 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.061 | ||
| FGF10 | fibroblast growth factor 10 | 0.054 | Human | |
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.047 | ||
| MSN | moesin | 0.044 | ||
| APP | amyloid beta (A4) precursor protein | 0.043 | ||
| IL8 | interleukin 8 | 0.040 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.039 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.039 | ||
| FGF7 | fibroblast growth factor 7 | 0.038 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.036 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.036 | ||
| EGFR | epidermal growth factor receptor | 0.034 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.033 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.031 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.030 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.027 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.026 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.026 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.026 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.025 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.022 | ||
| DCN | decorin | 0.022 | Zebrafish Mouse | |
| COL2A1 | collagen, type II, alpha 1 | 0.022 | ||
| INHBA | inhibin, beta A | 0.022 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.022 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.021 | ||
| STC1 | stanniocalcin 1 | 0.021 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.021 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.021 | ||
| ELN | elastin | 0.020 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.020 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.019 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.019 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.019 | ||
| PLAU | plasminogen activator, urokinase | 0.019 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.019 | ||
| FSTL1 | follistatin-like 1 | 0.019 | ||
| CNTF | ciliary neurotrophic factor | 0.019 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.018 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.018 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.018 | ||
| CAPRIN2 | caprin family member 2 | 0.018 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.018 | ||
| BMP1 | bone morphogenetic protein 1 | 0.017 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.017 | ||
| ACSL4 | acyl-CoA synthetase long-chain family member 4 | 0.017 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.017 | ||
| MRC2 | mannose receptor, C type 2 | 0.017 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.017 | ||
| FBN1 | fibrillin 1 | 0.016 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.016 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.016 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.016 | Human | |
| B3GAT3 | beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) | 0.016 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.016 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.015 | ||
| ZNF431 | zinc finger protein 431 | 0.015 | ||
| MAN1B1 | mannosidase, alpha, class 1B, member 1 | 0.015 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.015 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.015 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.015 | Rat | |
| VEGFC | vascular endothelial growth factor C | 0.014 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.014 | Human Rat | |
| PCOLCE | procollagen C-endopeptidase enhancer | 0.014 | ||
| LAMA2 | laminin, alpha 2 | 0.014 | ||
| CHPF | chondroitin polymerizing factor | 0.014 | Human Mouse | |
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.013 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.013 | ||
| DPT | dermatopontin | 0.013 | ||
| PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | 0.013 | ||
| BMP2 | bone morphogenetic protein 2 | 0.013 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.013 | Human | |
| CTSB | cathepsin B | 0.013 | ||
| CD81 | CD81 molecule | 0.013 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.013 | ||
| PRKCZ | protein kinase C, zeta | 0.013 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.013 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.013 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.012 | ||
| ARFGAP3 | ADP-ribosylation factor GTPase activating protein 3 | 0.012 | ||
| CCND2 | cyclin D2 | 0.012 | ||
| VCAN | versican | 0.012 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.012 | ||
| LUM | lumican | 0.012 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.012 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.012 | ||
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 0.012 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.012 | Rat | |
| ZEB2 | zinc finger E-box binding homeobox 2 | 0.012 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.012 | ||
| GPC1 | glypican 1 | 0.012 | ||
| ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.012 | ||
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.012 | Human Mouse | |
| B4GALT7 | xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) | 0.011 | ||
| FGG | fibrinogen gamma chain | 0.011 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.011 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.011 | ||
| FST | follistatin | 0.011 | ||
| EMILIN1 | elastin microfibril interfacer 1 | 0.011 | ||
| ACVR2B | activin A receptor, type IIB | 0.011 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.011 | ||
| OLFML3 | olfactomedin-like 3 | 0.011 | ||
| PID1 | phosphotyrosine interaction domain containing 1 | 0.011 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.011 | ||
| AP2B1 | adaptor-related protein complex 2, beta 1 subunit | 0.011 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.011 | ||
| CTSK | cathepsin K | 0.010 | ||
| BMX | BMX non-receptor tyrosine kinase | 0.010 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.010 | ||
| BCL2A1 | BCL2-related protein A1 | 0.010 | ||
| C7 | complement component 7 | 0.010 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.010 | ||
| CTSL1 | cathepsin L1 | 0.010 | ||
| LEPRE1 | leucine proline-enriched proteoglycan (leprecan) 1 | 0.010 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.010 | Human | |
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.010 | ||
| CRYAB | crystallin, alpha B | 0.010 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.010 | ||
| TLR2 | toll-like receptor 2 | 0.010 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.010 |